CIRCIO HOLDING (CRNA.OL) Stock Price, Quote, News and Overview
OSL:CRNA - Euronext Oslo - NO0013033795 - Common Stock - Currency: NOK
CRNA.OL Quote, Performance and Key Statistics
OSL:CRNA (4/25/2025, 7:00:00 PM)
0.81
+0.12 (+17.22%)
The current stock price of CRNA.OL is 0.81 NOK. In the past month the price increased by 52.83%. In the past year, price decreased by -70%.
CRNA.OL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 17.83 | 285.16B | ||
| AMG.DE | AMGEN INC | 14.07 | 131.97B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.26 | 112.70B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1657.31 | 110.78B | ||
| ARGX.BR | ARGENX SE | 352.5 | 32.72B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 24.54B | ||
| IDP.DE | BIOGEN INC | 7.16 | 15.20B | ||
| 0QF.DE | MODERNA INC | N/A | 9.45B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
| BIO.DE | BIOTEST AG | 65.23 | 1.68B | ||
| GLPG.AS | GALAPAGOS NV | N/A | 1.54B | ||
| BIO3.DE | BIOTEST AG-VORZUGSAKTIEN | 46.15 | 1.19B |
Related stock screener links
About CRNA.OL
Company Profile
Circio Holding ASA is a biotechnology company, which engages in developing novel circular RNA and immunotherapy medicines. The company is headquartered in Lysaker, Akershus and currently employs 10 full-time employees. The company went IPO on 2014-06-16. The firm is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The firm offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Company Info
CIRCIO HOLDING
Vollsveien 19
Lysaker AKERSHUS NO
Employees: 8
Company Website: https://www.circio.com/en/
Investor Relations: https://www.circio.com/en/financial-reports/
Phone: 4721398810
CIRCIO HOLDING / CRNA.OL FAQ
What is the stock price of CIRCIO HOLDING today?
The current stock price of CRNA.OL is 0.81 NOK. The price increased by 17.22% in the last trading session.
What is the ticker symbol for CIRCIO HOLDING stock?
The exchange symbol of CIRCIO HOLDING is CRNA and it is listed on the Euronext Oslo exchange.
On which exchange is CRNA.OL stock listed?
CRNA.OL stock is listed on the Euronext Oslo exchange.
What is the price forecast or stock price prediction for CIRCIO HOLDING stock?
7 analysts have analysed CRNA.OL and the average price target is 3.06 NOK. This implies a price increase of 277.78% is expected in the next year compared to the current price of 0.81. Check the CIRCIO HOLDING stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CIRCIO HOLDING worth?
CIRCIO HOLDING (CRNA.OL) has a market capitalization of 68.15M NOK. This makes CRNA.OL a Micro Cap stock.
How many employees does CIRCIO HOLDING have?
CIRCIO HOLDING (CRNA.OL) currently has 8 employees.
What are the support and resistance levels for CIRCIO HOLDING (CRNA.OL) stock?
CIRCIO HOLDING (CRNA.OL) has a support level at 0.56. Check the full technical report for a detailed analysis of CRNA.OL support and resistance levels.
Should I buy CIRCIO HOLDING (CRNA.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CRNA.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CRNA.OL, evaluating the profitability, health, valuation and growth aspects
- CIRCIO HOLDING (CRNA.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CIRCIO HOLDING (CRNA.OL) Sales and EPS estimates to see what analysts future expectations are.
- CIRCIO HOLDING (CRNA.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CIRCIO HOLDING (CRNA.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- CIRCIO HOLDING (CRNA.OL) Stock Chart to make your own analysis
- CIRCIO HOLDING (CRNA.OL) Latest news and press-releases to stay up to date.
Does CIRCIO HOLDING (CRNA.OL) stock pay dividends?
CRNA.OL does not pay a dividend.
When does CIRCIO HOLDING (CRNA.OL) report earnings?
CIRCIO HOLDING (CRNA.OL) will report earnings on 2025-08-28.
What is the Price/Earnings (PE) ratio of CIRCIO HOLDING (CRNA.OL)?
CIRCIO HOLDING (CRNA.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-15.68).
CRNA.OL Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to CRNA.OL. When comparing the yearly performance of all stocks, CRNA.OL is a bad performer in the overall market: 89.66% of all stocks are doing better.
CRNA.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CRNA.OL. Both the profitability and financial health of CRNA.OL have multiple concerns.
CRNA.OL Financial Highlights
Over the last trailing twelve months CRNA.OL reported a non-GAAP Earnings per Share(EPS) of -15.68. The EPS decreased by -581.6% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1479.04% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
CRNA.OL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to CRNA.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.